Monaco Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$767K Sell
25,600
-1,920
-7% -$54.5K 0.06% 45
2026
Q1
$826K Sell
27,520
-5,000
-15% -$166K 0.15% 54
2025
Q4
$1.06M Sell
32,520
-1,016
-3% -$32.8K 0.18% 63
2025
Q3
$1.16M Sell
33,536
-2,500
-7% -$80K 0.07% 61
2025
Q2
$1.01M Hold
36,036
0.18% 65
2025
Q1
$905K Buy
36,036
+21,036
+140% +$532K 0.18% 54
2024
Q4
$413K Sell
15,000
-5,999
-29% -$167K 0.06% 76
2024
Q3
$605K Hold
20,999
0.09% 63
2024
Q2
$520K Buy
20,999
+4,255
+25% +$121K 0.08% 55
2024
Q1
$539K Buy
16,744
+10,000
+148% +$372K 0.16% 53
2023
Q4
$274K Sell
6,744
-1,714
-20% -$63.1K 0.08% 71
2023
Q3
$292K Buy
8,458
+313
+4% +$12.2K 0.09% 64
2023
Q2
$331K Sell
8,145
-15,975
-66% -$652K 0.09% 61
2023
Q1
$932K Buy
24,120
+5,442
+29% +$224K 0.29% 48
2022
Q4
$829K Buy
18,678
+8,678
+87% +$365K 0.25% 55
2022
Q3
$426K Buy
+10,000
New +$512K 0.16% 59
2022
Q2
Sell
-17,000
Closed -$1.05M 71
2022
Q1
$1.05M Sell
17,000
-80,064
-82% -$4.9M 0.42% 34
2021
Q4
$5.35M Buy
+97,064
New +$5.06M 1.33% 12

Other funds holding LKFT

Monaco Asset Management's LKFT Position: Q2 2026 in Review

Monaco Asset Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 7% in Q2 2026, selling an estimated $54.5K and leaving 25,600 shares worth $767K. The position accounts for 0.06% of the portfolio, ranked #45.

Monaco Asset Management first reported a position in LKFT in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.35M in Q4 2021. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Monaco Asset Management held 25,600 shares of Lakefront Biotherapeutics American Depositary Shares worth $767K as of Q2 2026.
  • Monaco Asset Management sold 1,920 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $54.5K.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.06% of Monaco Asset Management's portfolio in Q2 2026, its #45 holding.
  • Monaco Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2021 and has held it in 18 quarters since.
  • Monaco Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $5.35M in Q4 2021.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Monaco Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.